史大卓教授治疗介入后冠心病遣方用药规律的关联性分析

doi:10.3969/j.issn.1673-7202.2018.08.034

首页 > 过刊浏览>2018年第卷第08期 >. DOI:10.3969/j.issn.1673-7202.2018.08.034

史大卓教授治疗介入后冠心病遣方用药规律的关联性分析
DOI:
                        10.3969/j.issn.1673-7202.2018.08.034
                    
CSTR:
                        
                    
作者:
                        
                        
                    
作者单位:
作者简介:
通讯作者:
中图分类号:
基金项目:国家十二五科技支撑计划项目（2013BAI02B01）——基于病证结合降低冠心病稳定期心血管事件的临床研究；中国中医科学院苗圃课题（ZZ11-066）——基于Choline/TMA/TMAO代谢通路研究黄连素抗动脉粥样硬化机制

Correlation Analysis of the Rules of Prescription and Medication of Coronary Heart Disease after Percutaneous Transluminal Coronary Intervention Treated by Professor Shi Dazhuo

Author:

Affiliation:

Fund Project:

摘要

图/表

访问统计

参考文献

相似文献

引证文献

资源附件

文章评论

摘要:

目的:基于数据挖掘技术分析史大卓教授辨治介入后冠心病的遣方用药特点和规律。方法:利用关联规则分析,采用WEKA实现的Apriori算法(即Agrawal研究提出的算法),进行中药组方配伍的关联规则知识发现。结果:史教授辨治介入后冠心病常用的中药配伍有:莪术配丹参、赤芍配丹参、黄连配丹参、莪术配赤芍、川芎配丹参、生黄芪配丹参、莪术配川芎;常用的多个药物配伍(药组)有:川芎、莪术、赤芍、丹参,莪术、赤芍、丹参,川芎、黄连、赤芍、丹参,莪术、川芎、丹参,莪术、川芎、赤芍,赤芍、生黄芪、川芎、丹参,黄连、丹参、赤芍,赤芍、川芎、丹参,黄连、川芎、丹参等。结论:史教授治疗介入后冠心病常用的重要组方配伍为丹参、赤芍、黄连、川芎、生黄芪,体现了他临床善用益气、活血、解毒的遣方用药特点。

Abstract:

To summary the characteristics and principles of prescription and medication of coronary heart disease (CHD) after percutaneous transluminal coronary intervention (PCI) that diagnosed and treated by Professor Shi Dazhuo.Methods:Using the association rule analysis，the Apriori algorithm implemented by WEKA (the algorithm proposed by Agrawal research) was used to discover the knowledge of association rules of Chinese medicine prescription compatibility.Results:The common compatibility of Chinese herbs used by Professor Shi was as follows：Rhizoma Curcumae with Radix Salviae Miltiorrhizae，Radix Paeoniae Rubra with Radix Salviae Miltiorrhizae，Rhizoma Coptidis with Radix Salviae Miltiorrhizae，Rhizoma Curcumae with Radix Paeoniae Rubra，Rhizoma Ligustici Chuanxiong with Radix Salviae Miltiorrhizae，Radix Astragali seu Hedysari with Radix Salviae Miltiorrhizae，Rhizoma Curcumae with Rhizoma Ligustici Chuanxiong.Drug groups commonly used were Rhizoma Ligustici Chuanxiong，Rhizoma Curcumae，Radix Paeoniae Rubra，Radix Salviae Miltiorrhizae; Rhizoma Curcumae，Radix Paeoniae Rubra，Radix Salviae Miltiorrhizae; Rhizoma Ligustici Chuanxiong，Rhizoma Coptidis，Radix Paeoniae Rubra，Radix Salviae Miltiorrhizae; Rhizoma Curcumae，Rhizoma Ligustici Chuanxiong，Radix Salviae Miltiorrhizae; Rhizoma Curcumae，Rhizoma Ligustici Chuanxiong，Radix Paeoniae Rubra; Radix Paeoniae Rubra，Radix Astragali seu Hedysari，Rhizoma Ligustici Chuanxiong，Radix Salviae Miltiorrhizae; Rhizoma Coptidis，Radix Salviae Miltiorrhizae，Radix Paeoniae Rubra; Radix Salviae Miltiorrhizae，Rhizoma Ligustici Chuanxiong，Radix Salviae Miltiorrhizae; Rhizoma Coptidis，Rhizoma Ligustici Chuanxiong，Radix Salviae Miltiorrhizae and so on.Conclusion:Professor Shi commonly used compatibility of Chinese herbs in the treatment of CHD are as follows：Radix Salviae Miltiorrhizae，Radix Paeoniae Rubra，Rhizoma Coptidis，Rhizoma Ligustici Chuanxiong，Radix Astragali seu Hedysari.The results revealed that Professor Shi focused on tonifying qi，promoting blood circulation，activating blood circulation and detoxification in the treatment of CHD after PCI.

参考文献

相似文献

引证文献

引用本文

柴华,张璇,曲华,李金根,姜众会,高铸烨,史大卓.史大卓教授治疗介入后冠心病遣方用药规律的关联性分析[J].世界中医药,2018,(08).

复制

文章指标

点击次数:
下载次数:
HTML阅读次数:
引用次数:

历史

收稿日期:2017-09-09
最后修改日期:
录用日期:
在线发布日期: 2018-09-10
出版日期:

引用本文

相关视频

分享

文章指标

历史

文章二维码